Patients with chronic kidney disease (CKD) need to avoid drugs with potential renal toxicity and CKD-stage contraindications. However, certain potentially harmful drugs such as benzodiazepines, opioids, antipsychotics, mood stabilizers may evade such classifications. Real-world evidence from Japan on prescribing patterns of such potentially harmful drugs and their association with kidney function decline remains limited.
Momo et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: